ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

Multi-drug resistance is a growing problem in the treatment of infectious diseases and the
widespread use of broad-spectrum antibiotics has produced antibiotic resistance for many …

Pseudomonas aeruginosa (P. aeruginosa) possesses a plethora of virulence determinants,
including the production of biofilm, pigments, exotoxins, proteases, flagella, and secretion …

Due to the severity of infections caused by P. aeruginosa and the limitations in treatment, it is
necessary to find new therapeutic alternatives. Thus, the use of silver nanoparticles (AgNPs) …

Background Novel methods are necessary to reduce morbidity and mortality of patients
suffering from infections with Pseudomonas aeruginosa. Being the most common infectious …

Methanolic (SME) extract of the biologically safe and edible cyanobacteria, Spirulina
platensis was used for the green fabrication of silver nanoparticles (AgNPs) …

Background Herein, we first time used the gum Moringa oleifera as reducing and capping
agent for successful synthesis of silver nitrate and zinc oxide nanoparticles (NPs) through …

Bacterial resistance to conventional antibiotics has become a clinical and public health
problem, making therapeutic decisions more challenging. Plant compounds and nanodrugs …

Antimicrobial resistance among pathogenic bacteria has become a global threat to human
health. Due to poor progress in development of new antimicrobial drugs, there is a need for …

Pseudmonas aeruginosa is a Gram-negative bacterium known to be ubiquitous and
recognized as one of the leading causes of infections such as respiratory, urinary tract …